| |
| Issue |
Title |
| |
| No 10 (2025) |
Risk factors associated with mortality in patients with multiple myeloma |
Abstract
PDF (Rus)
|
|
S. G. Bolotin, A. V. Solovieva, A. S. Pristupa, N. V. Sergeeva |
| |
| No 10 (2025) |
The effect of carcinoembryonic antigen on cytokine production in breast cancer patients |
Abstract
PDF (Rus)
|
|
A. A. Studenikina, S. L. Ryzhikova, A. V. Proskura, A. I. Autenshlyus |
| |
| No 10 (2025) |
Availability of innovative drugs for breast cancer therapy in Russia |
Abstract
PDF (Rus)
|
|
M. N. Denisova, A. A. Sinitsyna |
| |
| No 10 (2025) |
Remote results of treatment of patients of the Russian population with stage I–II non-small cell lung cancer (results of the observational study CARL-001) |
Abstract
PDF (Rus)
|
|
K. K. Laktionov, V. V. Breder, A. K. Allakhverdiev, A. M. Kazakov, A. E. Gorokhov, P. V. Kononets, D. I. Yudin, D. L. Stroyakovsky, Ya. S. Akhmadiyarova, V. V. Kozlov, A. M. Fedun, T. F. Ibragimov, T. A. Sannikova, I. V. Plokhotenko |
| |
| No 10 (2025) |
Efficacy of immune drugs in maintenance therapy after radical chemoradiation treatment of lung cancer: Results of real clinical practice |
Abstract
PDF (Rus)
|
|
A. V. Sultanbaev, I. A. Tuzankina, A. F. Nasretdinov, Sh. I. Musin, N. I. Sultanbaeva, K. V. Menshikov, I. A. Menshikova, A. A. Izmailov, D. A. Kudlay |
| |
| No 21 (2024) |
Experience with perioperative drug therapy in patients with stage III non-small cell lung cancer (results of the observational study CARL-001) |
Abstract
PDF (Rus)
|
|
K. K. Laktionov, V. V. Breder, A. K. Allahverdiev, A. M. Kazakov, A. E. Gorokhov, D. I. Yudin, D. L. Stroyakovskiy, Ya. S. Akhmadiyarova, V. V. Kozlov, A. M. Fedun, T. F. Ibragimov, T. A. Sannikova, I. V. Plokhotenko |
| |
| No 21 (2024) |
The possibilities of assessing regional risk factors for lung cancer |
Abstract
PDF (Rus)
|
|
S. V. Kapralov, S. V. Kustodov, O. M. Konopatskova |
| |
| No 21 (2024) |
Genomic characteristics of Russian patients with non-small cell lung cancer: Results of next-generation sequencing testing |
Abstract
PDF (Rus)
|
|
K. K. Laktionov, M. G. Gordiev, K. A. Sarantseva, I. A. Demidova, A. M. Stroganova, M. L. Filipenko, Yu. G. Zhusina, V. V. Karaseva, E. B. Kutirina, A. M. Kazakov, M. V. Soloveva |
| |
| No 21 (2024) |
Long-term results of surgical treatment of hepatocellular cancer in Russian real practice |
Abstract
PDF (Rus)
|
|
V. V. Petkau, R. I. Rasulov, A. A. Muratov, G. V. Nurbekyan, I. B. Uvarov, A. A. Kirshin, R. V. Orlova, N. V. Popova, M. S. Dinikin, R. Yu. Khlobystin, A. V. Sultanbaev, K. V. Menshikov, O. G. Orlov |
| |
| No 21 (2024) |
The effectiveness of a mobile mammography units in breast cancer screening |
Abstract
PDF (Rus)
|
|
D. A. Kaprin, V. I. Perkhov, M. N. Denisova |
| |
| No 10 (2024) |
Immune Checkpoint Inhibitors in first versus second line of metastatic non-small cell lung cancer: Real-World Overall Survival |
Abstract
PDF (Rus)
|
|
D. I. Yudin, К. К. Laktionov, V. V. Breder, K. A. Sarantseva, E. V. Reutova |
| |
| No 10 (2024) |
Impact of hepatocellular cancer screening on early diagnostics and overall survival: own data |
Abstract
PDF (Rus)
|
|
V. V. Petkau, E. N. Bessonova, A. A. Tarkhanov, M. V. Kartashov, M. A. Anashkina |
| |
| No 22 (2023) |
The results of therapy of patients with multiple myeloma in real clinical practice (results of a multicenter study) |
Abstract
PDF (Rus)
|
|
Yu. A. Zabolotneva, A. V. Gubkin, I. B. Lysenko, I. A. Kamaeva, A. O. Shakhzadova, K. G. Gurevich |
| |
| No 22 (2023) |
Efficacy of immunotherapy in patients with metastatic melanoma |
Abstract
PDF (Rus)
|
|
M. A. Lyadova, D. S. Fedorinov, M. V. Nosova, V. M. Tuleiko, A. S. Orlova, D. A. Vozniuk, K. V. Lyadov, V. N. Galkin |
| |
| No 22 (2023) |
Adjuvant oxaliplatin-based chemotherapy comparing observation alone after radical resection of metachronous metastases of colorectal cancer: interim analysis |
Abstract
PDF (Rus)
|
|
S. F. Evdokimova, L. V. Bolotina, A. L. Kornietskaya, D. V. Sidorov, A. D. Kaprin |
| |
| No 22 (2023) |
The use of ribociclib in real clinical practice: results of a single-center observational retrospective study |
Abstract
PDF (Rus)
|
|
A. V. Sultanbaev, I. V. Kolyadina, Sh. I. Musin, A. F. Nasretdinov, N. I. Sultanbaeva, K. V. Menshikov, I. A. Menshikova, V. E. Askarov, R. R. Rakhimov, D. O. Lipatov, O. N. Lipatov, M. V. Sultanbaev, V. M. Zabelin, A. A. Izmailov, R. T. Ayupov, A. A. Izmailov |
| |
| No 11 (2023) |
Organization clinical decision-making programs in the local practice of the region: problematic issues that determine the choice of therapy in the progression of endometrial cancer |
Abstract
PDF (Rus)
|
|
A. Yu. Goryainova, M. G. Leonov, R. A. Murashko, O. S. Tsirulnikova, O. Yu. Chukhrai |
| |
| No 11 (2023) |
Expanding the usage of osimertinib as adjuvant therapy for EGFR-mutated NSCLC: a model-based assessment of its impact on reducing cancer mortality in Russia |
Abstract
PDF (Rus)
|
|
N. A. Avxentyev, A. S. Makarov, N. N. Sisigina |
| |
| No 11 (2023) |
Analysis of the regional clinical use of CDK4/6 inhibitor ribociclib as a mechanism of integration of a research approach in drug provision |
Abstract
PDF (Rus)
|
|
A. Yu. Goryainova, R. A. Murashko, S. V. Sharov, A. I. Stukan, D. N. Kugaevsky, E. V. Lymar |
| |
| No 22 (2022) |
Plastic surgery of skin melanoma as a factor of better survival of patients |
Abstract
PDF (Rus)
|
|
S. A. Yargunin, Ya. N. Shoykhet, S. N. Pyatakov |
| |
| No 22 (2022) |
Optimal choice of drug antitumor treatment in patients with Fibrolamellar liver carcinoma |
Abstract
PDF (Rus)
|
|
E. Yu. Antonova, E. A. Moroz, I. A. Dzhanyan, A. Yu. Volkov, K. K. Laktionov, V. V. Breder |
| |
| No 9 (2022) |
Induction of ovarian steroidogenesis as an additional potential risk factor for progression in premenopausal patients with hormone-receptor-positive breast cancer receiving tamoxifen as adjuvant therapy |
Abstract
PDF (Rus)
|
|
A. Yu. Goryainova, A. I. Stukan, E. V. Lymar, Z. K. Khachmamuk, I. G. Selezneva |
| |
| No 9 (2022) |
Molecular genetic characteristics of colorectal cancer depending on the status of microsatellite instability |
Abstract
PDF (Rus)
|
|
K. A. Oganyan, A. A. Musaelyan, M. A. Kotikova, S. V. Lapin, V. D. Nazarov, M. A. Belyaev, A. A. Zakharenko, S. V. Orlov |
| |
| No 9 (2022) |
Projection into the future: combination of orphenadrine and diclofenac in patients with bone metastases |
Abstract
PDF (Rus)
|
|
G. R. Abuzarova, R. R. Sarmanaeva, S. V. Kuznetsov, N. M. Bychkova, Yu. V. Brazhnikova |
| |
| No 9 (2021) |
Combined treatment of patients with localized pancreatic cancer of elderly and senile age |
Abstract
PDF (Rus)
|
|
L. I. Moskvicheva, L. V. Bolotina, A. L. Kornietskaya, D. V. Sidorov, N. A. Grishin, M. V. Lozhkin, A. D. Kaprin |
| |
| No 4S (2021) |
Incidence and prognostic factors in patents (pts) with mutant BRAF (mBRAF) metastatic colorectal cancer (mCRC) in Russia |
Abstract
PDF (Rus)
|
|
M. Yu. Fedyanin, К M. Ehlsnukaeva, I. A. Demidova, D. L. Stroyakovskiy, Yu. A. Shelygin, А. S. Tsukanov, М. V. Panina, V. Р. Shubin, F. V. Moiseenko, E. Yu. Karpenko, L. V. Bolotina, A. V. Kudryavtseva, М. L. Filipenko, I. P. Oskorbin, L. Yu. Vladimirova, N. N. Timoshkina, О. I. Kit, А. М. Stroganova, S. L. Dranko, А. I. Senderovich, А. А. Tryakin, S. А. Tjulandin |
| |
| No 4S (2021) |
Ramucirumab with paclitaxel or FOLFIRI as second-line treatment in docetaxel-pre-treated patients with metastatic gastric cancer in real-world setting |
Abstract
PDF (Rus)
|
|
N. S. Besova, Т. А. Titova, А. А. Tryakin, Е. V. Artamonova, Е. S. Obarevich, D. L. Stroyakovskiy, О. Е. Kalinin, I. S. Stilidi |
| |
| No 4S (2021) |
The influence of accessibility of anticancer drug therapy on the target indicators of the oncological service |
Abstract
PDF (Rus)
|
|
V. V. Petkau, А. А. Karimova, S. А. Efremov, Е. А. Gruzdeva |
| |
| No 4S (2021) |
Enoxaparin sodium as a drug of choice for the treatment of thrombosis in oncology |
Abstract
PDF (Rus)
|
|
О. V. Somonova, А. L. Elizarova, Т. V. Davydova |
| |
| No 4S (2021) |
Prognostic groups in retroperitoneal well-differentiated and dedifferentiated liposarcomas |
Abstract
PDF (Rus)
|
|
А. Yu. Volkov, S. N. Nered, N. А. Kozlov, I. S. Stilidi, Р. Р. Arkhiri, Е. Yu. Antonova, S. А. Privezentsev |
| |
| No 20 (2020) |
Stereotactic hypofractive radiotherapy in the treatment of patients with lung cancer |
Abstract
PDF (Rus)
|
|
T. N. Borisova, A. V. Nazarenko, K. K. Laktionov, S. I. Tkachev, S. B. Alieva, V. V. Breder, O. P. Trofimova, V. V. Glebovskaya, A. A. Fedorova, D. T. Marinov, N. A. Meshcheriakova, S. M. Ivanov, S. G. Gerasimov |
| |
| No 20 (2020) |
Management of acneiform rash associated with anti-EGFR monoclonal antibody treatment |
Abstract
PDF (Rus)
|
|
E. A. Shatokhina, L. S. Kruglova, A. S. Polonskaia |
| |
| No 20 (2020) |
The dynamics of the incidence of breast cancer in the Moscow region (2011–2018) |
Abstract
PDF (Rus)
|
|
L. M. Kogoniya, V. I. Astashov, S. N. Minakov |
| |
| No 20 (2020) |
Russian multicenter experience of using talazoparib in the treatment of patients with BRCA-associated metastatic breast cancer |
Abstract
PDF (Rus)
|
|
T. Yu. Semiglazova, E. V. Lubennikova, L. V. Bolotina, R. V. Orlova, F. V. Moiseenko, A. V. Avramenko, E. V. Artemeva, S. A. Borozdina, A. A. Vakhitova, N. M. Volkov, I. P. Ganshina, Sh. A. Dzhalilova, L. G. Zhukova, B. S. Kasparov, A. A. Kachmazov, V. V. Klimenko, A. i. Kornietskaya, A. A. Meshcheryakov, A. A. Paichadze, A. N. Poltoratsky, O. E. Ryabishina, M. L. Stepanova, E. N Imyanitov |
| |
| No 9 (2020) |
Features of laboratory data in the early diagnosis of tumors and ovarian tumours |
Abstract
PDF (Rus)
|
|
N. V. Spiridonova, A. A. Demura |
| |
| No 9 (2020) |
Experience of using сrizotinib in patients with ALKpositive non-small cell lung cancer |
Abstract
PDF (Rus)
|
|
E. V. Reutova, L. V. Laktionova, D. T. Marinov, D. A. Peregudov, T. N. Borisova |
| |
| No 9 (2020) |
Study of EGFR expression in tumor tissue in patients with locally advanced oral cavity cancer receiving cetuximab therapy |
Abstract
PDF (Rus)
|
|
A. A. Lyanova, L. Yu. Vladimirova, E. P. Ulianova, A. E. Storozhakova, N. A. Abramova, I. L. Popova, M. A. Teplyakova, N. M. Tikhanovskaya, V. S. Myagkova, K. A. Novoselova, L. A. Ryadinskaya, L. K. Strakhova, E. A. Kalabanova |
| |
| No 9 (2020) |
Firsthand experience of chemoradiotherapy in patients with localized small cell lung cancer. Retrospective assessment |
Abstract
PDF (Rus)
|
|
A. E. Kuzminov, T. N. Borisova, V. V. Breder, E. V. Reutova, T. D. Barbolina, K. K. Laktionov |
| |
| No 9 (2020) |
Biopsychosocial approach in the rehabilitation of patients with operable breast cancer |
Abstract
PDF (Rus)
|
|
V. A. Kluge, T. Yu. Semiglazova, P. V. Krivorotko, E. V. Melnikova, V. V. Semiglazov, K. O. Kondrateva, S. G. Nazarova, M. A. Tynkasova, B. S. Kasparov, B. M. Adhamov, R. S. Pesotsky, K. Yu. Zernov, D. V. Kovlen, V. F. Semiglazov, A. V. Belyaev |
| |
| No 9 (2020) |
Analysis of prognostic factors for survival in the Russian population of patients with disseminated gastric cancer, who received ramucirumab as secondline therapy in the RAMSELGA trial |
Abstract
PDF (Rus)
|
|
N. S. Besova, T. A. Titova, Е. V. Artamonova, A. A. Tryakin, D. L. Stroyakovskiy, E. V. Perminova, D. Yu. Yukalchuk, D. M. Ponomarenko, N. P. Belyak, R. V. Orlova, G. M. Teletaeva, E. Yu. Ratner, A. S. Mochalova, O. O. Gordeeva, A. S. Zhabina, S. V. Gamayunov, A. V. Smolin, A. Yu. Povyshev, M. I. Andrievskikh, I. S. Stilidi |
| |
| 1 - 40 of 40 Items |
|
